| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 08/18/2005 | US20050182045 Fused ring 4-oxopyrimidine derivative |
| 08/18/2005 | US20050181393 Novel chelating agents and highly luminescent and stable chelates and their use |
| 08/18/2005 | CA2555491A1 Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof |
| 08/18/2005 | CA2555311A1 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands |
| 08/18/2005 | CA2555219A1 Synthesis of cyanoimino-benzoimidazoles |
| 08/18/2005 | CA2554217A1 Diaza- or thiazadione derivatives with neuroprotective activity |
| 08/18/2005 | CA2554050A1 Diazabicyclic aryl derivatives as cholinergic receptor modulators |
| 08/17/2005 | EP1564216A1 White organic fluorescent compound |
| 08/17/2005 | EP1564213A1 Imidazole derivative, process for producing the same, and use |
| 08/17/2005 | EP1564210A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 08/17/2005 | EP1562945A1 1,4-diazabicyclo(3,2,2)nonane derivatives, preparation and therapeutical use thereof |
| 08/17/2005 | EP1562944A1 Pyrazoloquinolines with immunomodulating activity |
| 08/17/2005 | EP1562943A1 Fused heterocyclic compounds |
| 08/17/2005 | EP1562942A1 Amorphous moxifloxacin hydrochloride |
| 08/17/2005 | EP1562935A1 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| 08/17/2005 | EP1562934A1 Amino-heterocycles as vr-1 antagonists for treating pain |
| 08/17/2005 | EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 08/17/2005 | EP1562931A2 Anti-infective biaryl compounds |
| 08/17/2005 | EP1562925A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/17/2005 | EP1562917A1 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders |
| 08/17/2005 | EP1562593A2 Topoisomerase-targeting agents |
| 08/17/2005 | EP1562589A2 Diaminotriazoles useful as inhibitors of protein kinases |
| 08/17/2005 | EP1562587A2 Novel compositions and methods for the treatment of immune related diseases |
| 08/17/2005 | EP1562574A1 2-oxo-ethanesulfonamide derivates |
| 08/17/2005 | EP1466174A4 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 08/17/2005 | EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 08/17/2005 | EP1161240B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 08/17/2005 | EP0991638B1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS |
| 08/17/2005 | CN1656109A Non nucleoside reverse transcriptase inhibitors |
| 08/17/2005 | CN1656096A Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders |
| 08/17/2005 | CN1656095A Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient |
| 08/17/2005 | CN1656094A 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 08/17/2005 | CN1656091A Tetrahydropyran derivatives |
| 08/17/2005 | CN1656079A Pyrazole compounds and pharmaceutical compositions comprising the compound |
| 08/17/2005 | CN1655788A 1H-imidazo[4, 5-c]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 08/17/2005 | CN1655781A Novel heterocyclic compounds which are active as inhibitors of beta-lactamases |
| 08/17/2005 | CN1215067C 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 08/17/2005 | CN1215061C Process for preparing anticancer compound, and intermediate |
| 08/16/2005 | US6930185 Anorectic agents; obesity; such as 4'-chloro-N-(6-((N,N-dimethylamino)methyl)-2-naphthyl)(1,1'-biphenyl)-4 -carbox-amide |
| 08/16/2005 | US6930114 Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors |
| 08/16/2005 | US6930113 For therapy and prophylaxis of sexual dysfunctios; hypertension, pulmonary hypertension, congestive heart failure, renal failure, myocardial infraction, stable, unstable and variant (Prinzmetal) angina, atherosclerosis |
| 08/16/2005 | US6930107 treating obesity, overweight condition, hyperlipidemia, thyroid disease, hypothyroidism, thyroid cancer and related disorders |
| 08/16/2005 | US6930104 beta -amyloid precursor protein secretory stimulators; treating neurodegenerative disorders; n-carbamoyl- quinoxaline or quinoline derivatives |
| 08/16/2005 | CA2323703C New cyano-indole serotonin reuptake inhibitors, the procedure for preparing them and the pharmaceutical formulations that contain them |
| 08/16/2005 | CA2220438C (n-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents |
| 08/11/2005 | WO2005073232A1 P38 kinase inhibitors |
| 08/11/2005 | WO2005073231A1 Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments |
| 08/11/2005 | WO2005073230A1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments |
| 08/11/2005 | WO2005073229A1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments |
| 08/11/2005 | WO2005073224A2 Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer |
| 08/11/2005 | WO2005073221A1 HETEROCYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
| 08/11/2005 | WO2005073203A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
| 08/11/2005 | WO2005073196A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING α-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME |
| 08/11/2005 | WO2005072735A1 Piperidinyl prostaglandin e analogs |
| 08/11/2005 | WO2005072732A1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
| 08/11/2005 | WO2005072361A2 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity |
| 08/11/2005 | WO2005065370A3 Soluble polymers as amine capture agents and methods |
| 08/11/2005 | WO2005058896A3 Synthesis of a polymorph of 4-amino-5-chloro-2-methoxy-n-(1-azabicyclo[3.3.1]non-4-yl)benzamide hydrochloride hydrate |
| 08/11/2005 | WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof |
| 08/11/2005 | WO2005046588A3 Compounds, compositions, and methods |
| 08/11/2005 | WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 08/11/2005 | US20050176970 Field-effect transistor; mono- and diimide perylene and naphthalene compounds, core-substituted with one or more electron-withdrawing groups, generating the radical anions electrochemically |
| 08/11/2005 | US20050176961 Reacting compounds such as 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid with 4-Aminomethyl-3-methoxyimino-pyrrolidinium dimethanesulfonate in presence of triethylamine or a tetraC1-6alkylammonium hydroxide, and an aqueous solvent |
| 08/11/2005 | US20050176959 Oxidation of dihydroquinacridone salt with peroxide in the presence of catalyst and anthraquinonedisulfonic acid as catalyst |
| 08/11/2005 | US20050176957 reacting nicotinic acid derivatives with amidine derivatives to yield substituted pyridopyrimidones |
| 08/11/2005 | US20050176955 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as hiv integrase inhibitors |
| 08/11/2005 | US20050176797 Thromboembolic disorders; e.g. 2-[5-(5-carbamimidoyl-1H-benzoimidazol-2-yl)-5'-fluoro-6,2'-dihydroxy-biphenyl-3-yl]-succinic acid |
| 08/11/2005 | US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/11/2005 | US20050176771 4-fluoro-1-({[1-(methanesulfonyl)piperidin-4-yl]amino}acetyl)pyrrolidine-2-carbonitrile; insulin-dependent diabetes (type 1 diabetes), non insulin-dependent diabetes (type 2 diabetes), insulin-resistant disorders, obesity; dipeptidyl peptidase IV-inhibiting activity |
| 08/11/2005 | US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders |
| 08/11/2005 | US20050176754 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 08/11/2005 | US20050176753 controlling signal transduction; anticancer agents; antitumor agnets; atherosclerosis; vision defects; antidiabetic agents; antiinflammatory agents |
| 08/11/2005 | US20050176751 Selective H1 histamine receptor antagonists; bronchial asthma, allergic rhinitis, conjunctivitis, dermatitis, urticaria and other allergic diseases; e.g. 3-(4-[1-(2-methoxyethyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]piperidin-1-ylmethyl)benzoic acid |
| 08/11/2005 | US20050176749 Modulators of glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof |
| 08/11/2005 | US20050176747 hypertension and asthma; vasorelaxants |
| 08/11/2005 | US20050176740 Synergistic for cancer characterized by ras oncogene overexpression; N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine |
| 08/11/2005 | US20050176731 N-[5-({(2S)-3-[(4-{4-[(4-benzylpiperidin-1-yl)carbonyl]phenyl}cyclohexyl)amino]-2-hydroxypropyl}oxy)-2-hydroxyphenyl]methanesulfonamide; beta 3 receptors agonist; gastrointestinal diseases; antiobesity, antidiabetic, cicatrizing agents, tocolytics, dysmenorrhea, antiglaucomatous; amidation |
| 08/11/2005 | US20050176726 Pyrimidine ether derivatives; antiinflammatory; analgesic; antiarthritis; antirheumatic;diseases involving sensory nerve function; 2-((6-(4-((1S)-1-(4-fluorophenyl)ethyl)-1-piperazinyl)-4-pyrimidinyl)oxy)quinoline |
| 08/11/2005 | US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/11/2005 | US20050176720 Pharmaceutical composition for the treatment of CNS and other disorders |
| 08/11/2005 | US20050176718 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
| 08/11/2005 | US20050176712 Integrin expression inhibitor |
| 08/11/2005 | US20050176706 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
| 08/11/2005 | US20050176702 1,8-Annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 08/11/2005 | US20050176701 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 08/11/2005 | US20050176700 (2-methoxyphenyl)acetic acid-7-{4-[3-(2-methoxybenzyloxy)-propoxy]phenyl}-3-(2-thiophen-2-ylacetyl)-3,9-diazabicyclo[3.3.1]non-6-en-6-yl-methyl ester; metabolically stable, orally bioavailable and sufficiently soluble; industrial scale; non-peptidic nature, low molecular weight |
| 08/11/2005 | US20050176699 Benzodiazepine derivatives, preparation thereof and use thereof |
| 08/11/2005 | DE102004003888A1 Mesoionische Pigmente Mesoionic pigments |
| 08/11/2005 | DE102004003735A1 Verfahren zur Herstellung von Terrylen-3,4:11,12-tetracarbonsäurediimiden Process for preparing terylene-3,4: 11,12-tetracarboxylic |
| 08/11/2005 | DE102004003734A1 Verfahren zur Herstellung von Terrylen-3,4:11,12-tetracarbonsäurediimiden durch Di-rektsynthese Process for preparing terylene-3,4: 11,12-tetracarboxylic by di-rektsynthese |
| 08/11/2005 | DE10138561B4 Tumorhemmende Cerverbindungen sowie deren Verwendung Tumor-inhibiting cerium compounds and their use |
| 08/11/2005 | CA2554527A1 Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments |
| 08/11/2005 | CA2554525A1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments |
| 08/11/2005 | CA2554522A1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments |
| 08/11/2005 | CA2554387A1 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity |
| 08/11/2005 | CA2553433A1 Quinoline quinazoline pyridine and pyrimidine compounds and their use in the treatment of inflammation angiogenesis and cancer |
| 08/11/2005 | CA2553387A1 Piperidinyl prostaglandin e analogs |
| 08/10/2005 | EP1561741A1 Method for deuteration or tritiation of heterocyclic ring |
| 08/10/2005 | EP1560835A1 Spirocyclic cyclohexane derivatives |
| 08/10/2005 | EP1560834A1 New tricyclic derivatives as ltd4 antagonists |